Torrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has informed stock exchanges that the trading window for dealing in its securities by Designated Persons will be closed from 1st October, 2025, in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's own code of conduct. The window will reopen 48 hours after the company submits its financial results for the quarter ended 30th September, 2025 (Q2 FY2026) to the exchanges. This is a routine, mandatory compliance intimation signed by Company Secretary Chintan M. Trivedi and filed with both BSE and NSE on 29th September, 2025. No financial figures or corporate actions are disclosed in this filing.
This is a standard regulatory compliance filing with no direct impact on shareholders or the stock price. However, it indirectly signals that Torrent Pharma's Q2 FY2026 financial results will be announced in the coming weeks, which investors should watch for.